A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
Condition(s):Prostate Cancer; Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)Last Updated:November 20, 2015Withdrawn
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer; Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)Last Updated:November 20, 2015Withdrawn
Condition(s):Chronic Coronary Syndrome; Non ST Segment Elevation Acute Coronary SyndromeLast Updated:May 3, 2023Recruiting
Condition(s):Ischemic Heart Disease; Stenotic Coronary Lesion; Cardiovascular Diseases; Arteriosclerosis; Coronary Artery DiseaseLast Updated:October 10, 2023Completed
Condition(s):Coronary Artery DiseaseLast Updated:April 8, 2020Completed
Condition(s):Pneumonia; Lung Abscess; PeritonitisLast Updated:April 26, 2017Completed
Condition(s):Acute Myeloid Leukemia; Acute Lymphoid LeukemiaLast Updated:June 15, 2023Completed
Condition(s):Metastatic Non-Squamous Non-Small Cell Lung CarcinomaLast Updated:January 10, 2024Active, not recruiting
Condition(s):Breast Cancer; Heart FailureLast Updated:March 21, 2024Not yet recruiting
Condition(s):Peripheral T Cell Lymphoma; Relapsed Peripheral T-Cell Lymphoma; Refractory T-Cell LymphomaLast Updated:December 11, 2023Recruiting
Condition(s):EpilepsyLast Updated:September 5, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.